glp-1 therapies success rate Proportion of Patients Who Discontinued RA Therapy, n=4791 GLP-1s vs Lifestyle Only Weight
Description
With the accelerated adoption of GLP-1s, contract development and manufacturing organizations (CDMOs) have become essential strategic partners for navigating the evolving landscape
The data in Table 1 reflect exposure of 1,673 adult patients to liraglutide injection and a mean duration of exposure to liraglutide injection of 37.3 weeks
1 , e00009 (2018)
GLP-1 medications are being studied for an expanding range of conditions including autoimmune conditions , cardiovascular risk reduction, non-alcoholic fatty liver disease, and neurodegenerative diseases
[36].Nguyen N.F
